124
Views
1
CrossRef citations to date
0
Altmetric
Letter

Graft failure after reduced-intensity stem cell transplantation for congenital sideroblastic anemia

, , &
Pages 46-51 | Received 24 Mar 2018, Accepted 23 Jan 2019, Published online: 26 Mar 2019

References

  • Munneke JM, Spruit MJ, Cornelissen AS, van Hoeven V, Voermans C, Hazenberg MD. The potential of mesenchymal stromal cells as treatment for severe steroid-refractory acute graft-versus-host disease: a critical review of the literature. Transplantation 2016;100(11):2309–2314.
  • Antin JH, Ferrara JL. Cytokine dysregulation and acute graft-versus-host disease. Blood 1992;80(12):2964–2968.
  • González MI, Caballero D, Vázquez L, et al. Allogeneic peripheral stem cell transplantation in a case of hereditary sideroblastic anaemia. Br J Haematol. 2000; 109:658–660. doi:10.1046/j.1365-2141.2000.02050.x.
  • Ayas M, Al-Jefri A, Mustafa MM, Al-Mahr M, Shalaby L, Solh H. Congenital sideroblastic anaemia successfully treated using allogeneic stem cell transplantation. Br J Haematol. 2001;113(4):938–939. doi:10.1046/j.1365-2141.2001.02855.x.
  • Urban C, Binder B, Hauer C, Lanzer G. Congenital sideroblastic anemia successfully treated by allogeneic bone marrow transplantation. Bone Marrow Transplant. 1992;10(4):373–375.
  • Kim MH, Shah S, Bottomley SS, Shah NC. Reduced-toxicity allogeneic hematopoietic stem cell transplantation in congenital sideroblastic anemia. Clin Case Rep. 2018;6(9):1841–1844. doi:10.1002/ccr3.1667.
  • Medeiros BC, Kolhouse JF, Cagnoni PJ, et al. Nonmyeloablative allogeneic hematopoietic stem cell transplantation for congenital sideroblastic anemia. Bone Marrow Transplant. 2003;31(11):1053–1055.
  • Fujiwara T, Okamoto K, Niikuni R, et al. Effect of 5-aminolevulinic acid on erythropoiesis: a preclinical in vitro characterization for the treatment of congenital sideroblastic anemia. Biochem Biophys Res Commun. 2014;454(1):102–108. doi:10.1016/j.bbrc.2014.10.050.
  • Bacigalupo A. How I treat acquired aplastic anemia. Blood 2017;129(11):1428–1436.
  • Zaidman I, Rowe JM, Khalil A, Ben-Arush M, Elhasid R. Allogeneic stem cell transplantation in congenital hemoglobinopathies using a tailored busulfan-based conditioning regimen: single-center experience. Biol Blood Marrow Transplant. 2016;22(6):1043–1048. doi:10.1016/j.bbmt.2016.03.003.
  • Abikoff CM, Cairo MS. Reduced intensity conditioning and hematopoietic stem cell transplantation in pediatric nonmalignant disease: a new therapeutic paradigm. J Pediatr. 2014;164(5):952–953.e2. doi:10.1016/j.jpeds.2014.01.061.
  • Storb R, Sandmaier BM. Nonmyeloablative allogeneic hematopoietic cell transplantation. Haematologica 2016;101(5):521–530. doi:10.3324/haematol.2015.132860.
  • Ohba R, Furuyama K, Yoshida K, et al. Clinical and genetic characteristics of congenital sideroblastic anemia: comparison with myelodysplastic syndrome with ring sideroblast (MDS-RS). Ann Hematol. 2013;92(1):1–9. doi:10.1007/s00277-012-1564-5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.